rs145583732
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000828.5(GRIA3):āc.159T>Cā(p.Phe53=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00101 in 1,205,559 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 390 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00084 ( 0 hom., 29 hem., cov: 22)
Exomes š: 0.0010 ( 0 hom. 361 hem. )
Consequence
GRIA3
NM_000828.5 synonymous
NM_000828.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.36
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant X-123185881-T-C is Benign according to our data. Variant chrX-123185881-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 435359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-123185881-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=2.36 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000843 (94/111487) while in subpopulation NFE AF= 0.00119 (63/53066). AF 95% confidence interval is 0.000951. There are 0 homozygotes in gnomad4. There are 29 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 29 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.159T>C | p.Phe53= | synonymous_variant | 2/16 | ENST00000622768.5 | |
GRIA3 | NM_007325.5 | c.159T>C | p.Phe53= | synonymous_variant | 2/16 | ENST00000620443.2 | |
GRIA3 | NM_001256743.2 | c.159T>C | p.Phe53= | synonymous_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRIA3 | ENST00000620443.2 | c.159T>C | p.Phe53= | synonymous_variant | 2/16 | 1 | NM_007325.5 | P4 | |
GRIA3 | ENST00000622768.5 | c.159T>C | p.Phe53= | synonymous_variant | 2/16 | 5 | NM_000828.5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000843 AC: 94AN: 111487Hom.: 0 Cov.: 22 AF XY: 0.000862 AC XY: 29AN XY: 33655
GnomAD3 genomes
AF:
AC:
94
AN:
111487
Hom.:
Cov.:
22
AF XY:
AC XY:
29
AN XY:
33655
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000873 AC: 160AN: 183339Hom.: 0 AF XY: 0.000752 AC XY: 51AN XY: 67799
GnomAD3 exomes
AF:
AC:
160
AN:
183339
Hom.:
AF XY:
AC XY:
51
AN XY:
67799
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00102 AC: 1118AN: 1094072Hom.: 0 Cov.: 30 AF XY: 0.00100 AC XY: 361AN XY: 359536
GnomAD4 exome
AF:
AC:
1118
AN:
1094072
Hom.:
Cov.:
30
AF XY:
AC XY:
361
AN XY:
359536
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000843 AC: 94AN: 111487Hom.: 0 Cov.: 22 AF XY: 0.000862 AC XY: 29AN XY: 33655
GnomAD4 genome
AF:
AC:
94
AN:
111487
Hom.:
Cov.:
22
AF XY:
AC XY:
29
AN XY:
33655
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 15, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 03, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2014 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at